Search research articles
Contact Us
Filters
Showing results (21-30 of 59) with videos related to
Page
of 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
September 9, 2024
Anti-Heat Shock Protein 70 Autoantibodies from Patients with Idiopathic Pulmonary Fibrosis Epigenetically Enhance Lung Fibroblast Apoptosis Resistance and Bcl-2 Expression
Baiyun Zhong, Jennifer Q Zhou, Xing Lyu, et al.
Clinical Transplantation
|
March 1, 2011
Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients
Gundeep S Dhillon, Vincent G Valentine, Joseph Levitt, et al.
The Journal of Biological Chemistry
|
January 6, 2019
Retraction: Down-regulated peroxisome proliferator-activated receptor γ (PPARγ) in lung epithelial cells promotes a PPARγ agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD)
Sowmya P Lakshmi, Aravind T Reddy, Yingze Zhang, et al.
The Journal of Biological Chemistry
|
December 26, 2013
Down-regulated peroxisome proliferator-activated receptor γ (PPARγ) in lung epithelial cells promotes a PPARγ agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD)
Sowmya P Lakshmi, Aravind T Reddy, Yingze Zhang, et al.
Plos One
|
July 21, 2015
Correction: Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Michael Donahoe, Vincent G Valentine, Nydia Chien, et al.
BMC Pulmonary Medicine
|
March 21, 2024
Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis
Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, et al.
Plos One
|
June 18, 2015
Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Michael Donahoe, Vincent G Valentine, Nydia Chien, et al.
Research Square
|
March 11, 2024
Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 12, 2008
CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients
Sean M Studer, M Patricia George, Xuehai Zhu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 13, 2018
Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5
Yong Wang, Cara C Schafer, Kenneth P Hough, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 59) with videos related to
Sort By:
Page
of 6
Journal of Immunology (Baltimore, Md. : 1950)
|
September 9, 2024
Anti-Heat Shock Protein 70 Autoantibodies from Patients with Idiopathic Pulmonary Fibrosis Epigenetically Enhance Lung Fibroblast Apoptosis Resistance and Bcl-2 Expression
Baiyun Zhong, Jennifer Q Zhou, Xing Lyu, et al.
Clinical Transplantation
|
March 1, 2011
Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients
Gundeep S Dhillon, Vincent G Valentine, Joseph Levitt, et al.
The Journal of Biological Chemistry
|
January 6, 2019
Retraction: Down-regulated peroxisome proliferator-activated receptor γ (PPARγ) in lung epithelial cells promotes a PPARγ agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD)
Sowmya P Lakshmi, Aravind T Reddy, Yingze Zhang, et al.
The Journal of Biological Chemistry
|
December 26, 2013
Down-regulated peroxisome proliferator-activated receptor γ (PPARγ) in lung epithelial cells promotes a PPARγ agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD)
Sowmya P Lakshmi, Aravind T Reddy, Yingze Zhang, et al.
Plos One
|
July 21, 2015
Correction: Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Michael Donahoe, Vincent G Valentine, Nydia Chien, et al.
BMC Pulmonary Medicine
|
March 21, 2024
Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis
Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, et al.
Plos One
|
June 18, 2015
Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Michael Donahoe, Vincent G Valentine, Nydia Chien, et al.
Research Square
|
March 11, 2024
Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Tejaswini Kulkarni, Gerard J Criner, Daniel J Kass, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 12, 2008
CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients
Sean M Studer, M Patricia George, Xuehai Zhu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 13, 2018
Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5
Yong Wang, Cara C Schafer, Kenneth P Hough, et al.
Page
of 6